Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Equity ETF median (66 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 11 Mar 2025 – 20 Aug 2026, limited by Mirae Asset BSE 200 Equal Weight ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset BSE 200 Equal Weight ETF | Nifty 500 |
|---|---|---|
| 11 Mar 2025 | ₹100.00 | ₹100.00 |
| 24 Apr 2025 | ₹109.95 | ₹109.25 |
| 07 Jun 2025 | ₹115.16 | ₹114.10 |
| 21 Jul 2025 | ₹116.17 | ₹115.15 |
| 03 Sep 2025 | ₹113.89 | ₹112.62 |
| 17 Oct 2025 | ₹117.06 | ₹116.23 |
| 30 Nov 2025 | ₹118.94 | ₹117.88 |
| 12 Jan 2026 | ₹117.33 | ₹115.80 |
| 25 Feb 2026 | ₹118.86 | ₹115.28 |
| 10 Apr 2026 | ₹114.10 | ₹110.07 |
| 24 May 2026 | ₹117.92 | ₹111.57 |
| 07 Jul 2026 | ₹120.94 | ₹115.10 |
| 20 Aug 2026 | ₹123.31 | ₹115.81 |
| Metric | Mirae Asset NAV ₹13.99 Very High risk ★★★★☆ 1Y | Category median Equity ETF · 66 funds |
|---|---|---|
| +7.58% | +3.95% | |
| — | +11.55% | |
| — | +10.41% | |
| — | +11.81% | |
| +15.63% | +8.19% | |
| +9.84% | — | |
| — | +13.71% | |
| — | +14.22% | |
| — | +12.98% | |
| Risk | ||
| 15.51% | 17.16% | |
| 0.07 | 0.22 | |
| 0.10 | 0.32 | |
| -13.58% | -20.98% | |
| Nifty 500 | — | |
| — | +0.65% | |
| — | 1.00 | |
| — | 101.0% | |
| — | 97.0% | |
| 0.49% | 0.37% | |
| ₹19.13Cr | ₹91.02Cr | |
| 0.05% | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| — | — | |
| Vishal Singh · 1.5y | — | |
| 11 Mar 2025 | — | |
| — | — | |
| — | — | |
| 0.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.